Related Experiment Video
Updated: Jan 28, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Periprocedural Myocardial Infarction in Contemporary Practice
David W Lee1, Matthew A Cavender1
1Division of Interventional Cardiology, University of North Carolina, 160 Dental Circle, CB 7075, Chapel Hill, NC 27599, USA.
Abstract:
"Periprocedural myocardial infarction (MI) occurs infrequently in the current era of percutaneous coronary interventions (PCI) and is associated with an increased risk of mortality and morbidity. Periprocedural MI can occur due to acute side branch occlusion, distal embolization, slow flow or no reflow phenomenon, abrupt vessel closure, and nonidentifiable mechanical processes. Therapeutic strategies to reduce the risk of periprocedural MI include dual antiplatelet therapy, intravenous cangrelor in the periprocedural setting, intravenous glycoprotein IIb/IIIa inhibitor in high-risk patients, anticoagulation with unfractionated heparin, low-molecular-weight heparin or bivalirudin, and embolic protection devices during saphenous vein graft interventions."
Insights
Periprocedural myocardial infarction (MI) is uncommon but serious after percutaneous coronary interventions (PCI). Strategies like dual antiplatelet therapy and anticoagulation can reduce its risk.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Periprocedural myocardial infarction (MI) is a rare but significant complication following percutaneous coronary interventions (PCI).
- It is associated with elevated risks of mortality and morbidity.
Purpose of the Study:
- To review the causes and therapeutic strategies for reducing periprocedural MI in the context of contemporary PCI.
Main Methods:
- Literature review of periprocedural MI causes and management.
- Analysis of therapeutic interventions including antiplatelet therapy, anticoagulation, and embolic protection.
Main Results:
- Periprocedural MI can result from acute side branch occlusion, distal embolization, slow-flow/no-reflow, abrupt vessel closure, or mechanical issues.
- Effective strategies include dual antiplatelet therapy, cangrelor, glycoprotein IIb/IIIa inhibitors, various anticoagulants, and embolic protection devices.
Conclusions:
- Minimizing periprocedural MI requires a multifaceted approach combining pharmacotherapy and device-based interventions.
- Proactive management is crucial for improving patient outcomes after PCI.
Related Concept Videos
Contemporary Psychology
Biopsychology
Biopsychology, also known as biological psychology or behavioral neuroscience, focuses on the biological underpinnings of behavior and mental processes. It...
Characteristics of Practical Op Amps
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...
Theoretical Foundations of Nursing Practice
Theories provide a perspective to assess patients' conditions and organize data and methods. They also assist in analyzing and interpreting information. They represent a...
Equivalent Circuits for Practical Transformers
In a practical transformer, each winding exhibits resistance and leakage reactance. The...
The Quantum-Mechanical Model of an Atom
Sustainable Development

